MissionIR Small-Cap Investor Blog: June 2011

Thursday, June 30, 2011

China Botanic Pharmaceutical Inc. (CBP) Receives Patent for Siberian Ginseng Extraction Process

China Botanic Pharmaceutical Inc. is a company on the rise. Located in Harbin, China, this young company has quickly earned a reputation for their research, development, manufacturing, and distribution of botanical products and bio-pharmaceutical products. Today, China Botanic took a major step towards prominence with announcement they have been granted a patent from the State Intellectual Property Office of the People’s Republic of China for its Siberian Ginseng.

The patent is No. ZL200710301682X and will not only protect the Siberian Ginseng (Acanthopanax) but will also protect the resulting Siberian Ginseng extracts and their application will provide market exclusivity for a period of 20 years.

The patent covers a wide variety of possible Siberian Ginseng extraction methods and applications, creating a high barrier to entry for competitors seeking to develop similar Siberian Ginseng products, and, as a result, it confers significant independent intellectual property rights. These medicines are state-of-the-art in that they are powerful new tools in combating depression and senile dementia and have been recognized as “class one new drugs” and “innovative drugs” by the State Food and Drug Administration of China.

Leading the team at China Botanic is Mr. Shaomin Li whom serves as the Chairman and CEO of the evolving company. Li stated, “It is highly gratifying to receive patent protection for our advancements in the treatment of depression using all-natural Siberian Ginseng extracts. With our exclusive access to a large proportion of the Siberian Ginseng resources, and now this important protection for the extracts we obtain from the plant, our methods of preparation and their applications, we feel this is a major step forward. The issuance of this patent will enhance the commercial potential of our Siberian Ginseng applications in China, one of the largest markets for depression therapies, and further strengthen our leading market position.”

Currently, China Botanic is trading in the $0.80 range. To learn more about their new patent and the company as a whole, visit the corporate website at: www.renhuang.com

About MissionIR:

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Vista Gold Corp. (VGZ) Reports on Australian Drilling Program

Vista Gold Corp. reported the initial results of an exploratory drilling program at the company’s gold property in

Australia

In 2010, Vista Gold initiated a bankable feasibility study at the Mt. Todd project, located in Northern Territory, Australia. The company is investigating whether gold can be produced in commercial quantities from the Batman deposit at the site.

The first phase of this study involved drilling ten holes into the Batman deposit, and obtaining 5,740 meters of samples. The samples were then sent to ALS-Chemex, Genalysis Laboratory Services and North Australia Laboratories for multiple assay tests.

Vista Gold reported that the results of the initial phase confirm the mineralization of the Batman deposit and provide information for future drilling programs at the property. The company said that the results also extend that mineralization to the eastern side of the deposit.

Vista Gold estimates that prior to the recent drilling program, the proven and probable gold reserves present in the Batman deposit was 4.1 million ounces, with measured and indicated gold resources of 1 million ounces.

Vista Gold said that the company is working on a new resource estimate incorporating the results of the recent drilling program and expects to be finished by August 2011.

For more information on the company, go to http://www.vistagold.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Scorpex, Inc. (SRPX) Takes on Mexico’s Growing Baja Peninsula

In much of Mexico, the rules for waste management are changing, reflecting a growing population, tourism, and industrialization. In an attempt to tighten up waste management regulations, the General Law for Waste Prevention and Waste Integral Management was published in the Official Federal Bulletin for Mexico, and it became clear that additional resources were needed to address Mexico’s most severe waste management problems.

Nowhere is the subject of waste management more relevant than on Mexico’s Baja Peninsula, the long strip of land running 775 miles from the southern border of California south to Cabo San Lucas, dividing the Pacific Ocean from the Gulf of California. The area is a relatively large generator of waste in comparison to other parts of Mexico, as tourists and providers move in to take advantage of incomparable weather, a vast string of magnificent beaches, and a growing resort and hospitality industry. Agricultural waste is also growing, from areas suitable for growing citrus fruits, grapes, and other popular products, and the mining industry continues to develop.

Enter Scorpex, a Nevada-based company taking the necessary steps to build a full service waste disposal and recycling company, including toxic and hazardous waste, to serve the Baja California region of Mexico in the northern half of the peninsula. Scorpex Mexico corporate headquarters are located in Rosarito in Baja California, and the first Scorpex waste processing plant is being developed in nearby Ensenada.

The company has carefully planned and designed the facility, working closely with community representatives and expert consultants, and has complied with all legal and business requests at every level. As a result, the Mexican government has fully endorsed the Scorpex project, and a significant amount of construction has already been completed.

For additional information on Scorpex, visit the company’s website at www.Scorpex.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Inovio Pharmaceuticals (INO) Prostate Cancer Vaccine Shows Success in Primate Trial

Inovio Pharmaceuticals Inc., a leading developer of therapeutic and preventive vaccines, today announced that its SynCon ™ therapeutic DNA vaccine (INO-5150) for prostate cancer demonstrated positive immune responses in monkeys.

The company said the results support similarly strong, antigen-specific and sustainable T cell levels in previously reported data from earlier animal studies. Inovio said the new data reinforces its plan to a start phase I clinical trial for INO-5150 by the middle of next year.

Dr. J. Joseph Kim, Ph.D., president & CEO of Inovio, emphasized the potential of the vaccine in human models.

“The immune response data achieved by our SynCon™ prostate cancer vaccine in this large animal study is exceptional. It reinforces the repeatedly and consistently strong, long-lasting immune responses achieved by Inovio’s DNA vaccine platform against multiple cancers as well as other diseases,” Dr. Kim stated in the press release. “We are optimistic about the potential of this therapeutic vaccine in our planned prostate cancer human study and broadly speaking for cancers in general, including our currently progressing cervical cancer and leukemia phase II clinical studies.”

Inovio is currently manufacturing clinical grade INO-5150 with the goal of launching its planned phase I study in mid-2012. The company plans on enrolling a total of 148 patients across 25 study centers in the US., Korea, South Africa, Australia and Canada.

Inovio is currently conducting a phase II study for its cervical cancer vaccine. The randomized, placebo controlled, double blind study as designed to evaluate the effects of VGX-3100 treatment on the clearance of moderate or severe cervical intraepithelial neoplasia (CIN 2/3) cervical lesions.

For more information visit www.inovio.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Callidus Software Inc. (CALD) Partners with Mapping Analytics to Provide a New Paradigm in Sales Performance Management Software/Service

Callidus Software, a top market and tech leader in Sales Performance Management (SPM) via Software-as-a-Service (SaaS) applications, reported today that the Company has officially partnered (signed in Q2) with makers of the revolutionary ProAlign® Sales Territory Alignment and Optimization solution, Mapping Analytics.

Senior VP of Marketing at CALD, Lorna Heynike, laid it all out very clearly, stating that the key to optimal sales performance is the ability to blanket a market and provide total coverage. Heynike asserted that the Mapping Analytics partnership is wholly consistent with this objective as CALD will now be able to vastly extend the Company’s Monaco On Demand SPM suite handsomely, providing exemplary territory management capabilities, enabled by an integrated mapping system for powerful visualization that allows for rapid alignment of territories across multiple regions. Heynike pointed out the immediately obvious benefit to customers, who will get a higher return on investment in their sales force, being able to quickly optimize and map personnel load to vectors like customer concentration, overall workload and sales potential.

The efficiency upgrade this solution enables is remarkable and the partnership makes complete sense from a strategic standpoint. The power of the Mapping Analytics’ ProAlign® Sales Territory Alignment & Optimization Software framework allows a business to map strategic endpoints like company locations, customers, prospects, sales people and just about any other salient target. Basically, they have a solution that dynamically auto-creates balanced solution sets for territories based on a wide variety of inputs, anyone who has ever managed a large sales force can immediately grasp the technical functionality and overall efficiency such a solution provides.

President of Mapping Analytics, Ralph Rothfelder, commented on the partnership and extolled the resultant, which he affirmed benefits both from the superior ProAlign mapping technology and Callidus’ award-winning, full-spectrum sales talent lifecycle solutions.

Because Callidus’ products address the entire lifecycle from onboarding to incentivisation structures, ongoing training/mentoring and user-centric performance optimization, the complete transparency and visibility of the underlying process yields surety of analysis regarding operational and financial performance. This really offers unprecedented capabilities for customers to effectively manage the sales force and to simultaneously focus more on channeling key business objectives in order to maximize sales.

Because the ProAlign solution leverages ESRI ArcGIS®, the world’s top geographic mapping environment and is fully integrated with the Alteryx® geographic business intelligence platform, we get an end product that seamlessly feeds custom data through a dynamic software environment. This environment surpasses all expectations for analytical and report development tasks.

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

FBI Purchase of Arista Power (ASPW) Renewable Energy System Hints at Market Potential

Arista Power Inc., a diversified renewable energy product and services manufacturer, recently received an order for a Mobile Renewable Power Station (MRPS) from the Federal Bureau of Investigation (FBI) Audio Technology Deployment Unit Power Sources Program.

The FBI’s order includes Arista’s patented, ducted WindTamer wind turbine, as well as solar cells, fuel cells, and energy storage and power distribution system. The system was designed to replace diesel fuel generators, providing continuous operations. Since the system can be transported by commercial vehicles, the FBI can implement the MRPS system to power its communications equipment even in remote locations.

Nick Foundos, electrical engineer and program manager of the FBI’s Audio Technology Deployment Unit Power Sources Program, detailed how Arista’s comprehensive offerings complement the FBI’s program’s energy needs.

“We are procuring the Arista Power MRPS as we feel it will meet the needs of our application by combining wind, solar, fuel cells and energy storage into a reliable renewable power station. We are extremely impressed with the engineering capabilities of the Arista Power team and look forward to fielding the MRPS,” Foundos stated in the press release.

Arista noted the uniqueness of the MRPS, and said it expects receiving more orders based on increasing interest in its programs.

“There is no other system like ours,” said William Schmitz, CEO of Arista. “We see our system as a cost-effective alternative to using diesel generators in the field. Our system is versatile, scalable, reduces the number of site visits for refueling, and can be custom-designed to incorporate a variety of technologies to service virtually any power requirement. Remote monitoring is a rapidly growing application. We are seeing increasing interest in our Mobile Renewable Power Station, both in the commercial market and from a number of government agencies, including the U.S. Army, and we expect additional orders going forward.”

For more information visit www.aristapower.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Wednesday, June 29, 2011

CAMAC Energy, Inc. (CAK) Reports Results of Annual Shareholder Meeting

CAMAC Energy, Inc., a U.S.-based energy company focused on the exploration, development and production of oil and gas, today announced that at the recent annual general meeting, William J. Campbell, J. Kent Friedman and Ira Wayne McConnell were elected as independent directors of the company.

Mr. Campbell has nearly thirty years of experience in the legal, investment and energy industries with a diverse background in management, finance, legal, land and marketing. Since 2006, Mr. Campbell has served as owner and managing director of PPPCo-CB Energy, LLC, a Houston, Texas-based private and gas exploration and production company, and since 1997 Mr. Campbell has served as owner and managing director of CB Energy, LLC, a Houston, Texas-based private oil and gas exploration and production company.

Mr. Friedman is a veteran corporate and transactional lawyer with a long history of contributing to the civic and cultural life of Houston, Texas. Mr. Friedman is currently a partner in the Public Law Practice Group in the Houston office of Haynes and Boone, LLP, which he joined in January of 2011, and since May of 2000 has served as Vice Chairman of the Board and General Counsel of MAXXAM Inc., a Houston-based diversified, non-reporting public holding company with extensive interests in various businesses. Prior to joining MAXXAM, from 1982 to 1999 Mr. Friedman was a partner of the law firm Mayor, Day, Caldwell & Keeton, where he was one of the founding partners and served as the Managing Partner for over a decade.

Mr. McConnell is the Managing Partner of Houston, Texas-based McConnell & Jones LLP, Certified Public Accountants, where he is responsible for guiding the strategic direction of the firm and has overall responsibility for management of administrative functions, accounting, and information technology and is also Partner-In-Charge of the firm’s assurance practice. He founded McConnell & Jones in July of 1987. Mr. McConnell is also active in the public services sector, serving as a board member of the Houston Division of the American Heart Association since 2003, as a board member of the SouthWest Affiliate of the American Heart Association since 2008, and as the former Chairman of the Audit Committee of the American Heart Association National Board.

CAMAC Energy also announced that Dr. Kase Lawal, the company’s current Chairman and Chief Executive Officer, has agreed to continue in his role as CEO for the next 12 months, with the company’s executive search recommencing in 2012. Dr. Lawal commented: “I am pleased to continue in this key executive management position with the Company, which we believe will help strengthen and stabilize our management team as we position the Company for future growth and opportunities.”

The company has provided a full list of board members and their full biographies via the recent proxy statement filed with the SEC on May 13, 2011 which is available at www.sec.gov or through the CAMAC Energy website, www.camacenergy.com

About MissionIR:

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

U.S. Patent and Trademark Office Issues SEFE, Inc. (SEFE) Patent for Atmospheric Electrical Generator

SEFE, Inc., an alternative energy company focused on harvesting static electricity from the atmosphere and translating it into a form for usable power, announced this morning that it has been issued patent 7,855,476B2 for its Atmospheric Electrical Generator. The patent, filed in 2008 by SEFE Chief Technology Officer Mark Ogram but owned by SEFE, Inc., is the first of several patents that the company has submitted to the U.S. Patent and Trademark Office.

“The Atmospheric Electrical Generator is at the core of our intellectual property portfolio,” stated Mr. Ogram. “Inventions such as these are what will allow us to stay at the forefront of this rapidly growing industry. The Atmospheric Generator is important because it will serve as a cornerstone. We are witnessing a shift in the scientific community toward the belief that this energy source, which we have always recognized as having prevalence in our environment, is not as impossible to utilize as has been previously thought.”

Ogram, the principal inventor of the patent, received his BS and MS in Systems Engineering at the University of Arizona in Tucson. Subsequently, he had tenure as a Test Engineer with Hughes Aircraft, after which he attended Pepperdine University in Malibu, CA, receiving his Law Degree (JD) in 1979 and becoming a Patent Attorney with Texas Instruments, Inc. in Dallas, TX. He then returned to private practice in Tucson, AZ. SEFE’s Atmospheric Electrical Generator is the tenth issued patent in which Mr. Ogram has been involved.

SEFE, Inc. is currently pursuing an additional three pending patents with the USPTO and continues to develop its portfolio of trade secrets, patents, and other forms of intellectual property as an ancillary source of value to its investors.

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

AdCare Health Systems, Inc. (ADK) Inks $38.5M Acquisition in-line with M&A Strategy

AdCare Health Systems, Inc., a leading senior living and healthcare facility management provider, yesterday announced it will acquire, lease or become the manager of 15 skilled nursing facilities in South Carolina, North Carolina, Virginia and Tennessee for $38.5 million, representing the company’s largest acquisition thus far.

Two of the facilities are to be purchased, nine leased, and four managed by AdCare. With an aggregate of nearly 2,000 beds, the facilities generate an estimated $93 million in gross annualized revenues, which are expected to be immediately accretive to AdCare’s earnings upon completion of the transaction in the fall.

Including previously announced transactions, AdCare’s estimated annualized revenue run-rate is anticipated to top $268 million, a more than 400 percent increase over 2010 revenues and an increase of more than 900 percent over revenues in 2009 when the company launched its current M&A campaign.

“This agreement brings the total number of facilities we’ve put under contract to 46 since we began our M&A campaign in the fall of 2009, and is by far our largest transaction to-date,” Chris Brogdon, AdCare’s vice chairman and chief acquisitions officer stated in the press release. “It represents our first entrance into South Carolina, Virginia and Tennessee, and expands our presence in North Carolina. The addition of these facilities is in line with our expansion into the Southeast, and will leverage the support staff we’ve already established in the region.”

The company is also evaluating additional acquisition opportunities in the Midwest and said it will continue to focus on its current M&A plan in the second half of 2011.

For more information visit www.adcarehealth.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Tri-Tech (TRIT) Secures $20M Contract for Expansion of Water Treatment Plant in China

Tri-Tech Holding Ind., a China-based water treatment and odor/pollution control company, yesterday announced it has been awarded the contract for the expansion phase of the water treatment plant for the City of Ordos, valued at approximately $20 million. This phase is a follow up to the initial contract the company received in 2010.

Tri-Tech co-president Gavin Cheng noted that adverse winter weather conditions slowed the company’s construction efforts for the initial phase, which are now 70 percent complete. Cheng said the company’s ability to utilize its technology and project managers to combat the conditions earned the company the expansion phase of the project.

“We were very pleased to be awarded the expansion contract after our ongoing success with the initial phase construction … Following the completion of the initial and expansion phases, the Ordos plant will be the world’s largest treatment facility that uses ultra filtration and nano-filtration membrane technology …,” Tri-Tech CEO Warren Zhao stated in the press release.

The terms of the contract of expansion phase call for Tri-Tech to provide services of design optimization, procurement, installation, startup and commissioning, owner’s personnel training, operation and maintenance manual preparation of water treatment plant, and other services as needed.

China is ridden with heavily polluted water sources, which has prompted the Chinese government to issue new drinking water standards to be effective 2012.

“National policy places great emphasis on upgrading China’s water infrastructure. We believe this policy presents a huge market opportunity for our company. The Ordos water treatment plant project will be a highly visible example of our ability to execute large projects, deploy market resources and capital and implement innovative technology,” Zhao stated.

Tri-Tech co-president Phil Fan emphasized the importance of improved wastewater treatment to meet new drinking water standards in China and abroad.

“There is an urgent need for conventional water plants to be upgraded and to enhance wastewater treatment and reduce pollutant emissions, gradually reaching new drinking water standards in the country. Tri-Tech is continuously researching new and advanced membrane technology, disinfection technology, online monitoring technology, zero emission technologies and seawater utilization technology both in China and abroad,” Fan stated. “We have begun earnest cooperation with the manufacturers and research institutions and we are continuously driving the implementation of the latest and most sophisticated water and wastewater treatment technology for domestic municipal and industrial applications.”

Please visit http://www.tri-tech.cn for more information

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Tuesday, June 28, 2011

SANUWAVE, Inc. (SNWV) is “One to Watch”

SANUWAVE, Inc., a Georgia based company, is specializing in the development and commercialization of non-invasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal, and vascular structures. Their lead product candidate, called dermaPACE®, utilizes high energy acoustic pressure waves to treat chronic wounds, effectively enhancing the body’s own healing process. Most recently, the non-invasive device was shown to significantly decrease the size of diabetic foot ulcers, confirming just one of many markets to which the technology is expected to be applied.

The proprietary technology is now being developed for treating a wide range of diverse conditions, including burns, wounds, skin eruptions, cellulite treatment, orthopedic/spine applications, improving bone density in osteoporosis, eliminating chronic pain from trauma and arthritis, blood flow stimulation, and possibly even removing plaque due to atherosclerosis. Treatment does not require anesthesia, is quick and easy to administer, and is highly cost effective.

It’s all based upon acoustic pressure waves delivered in the shock-wave acoustic spectrum, a form that results in revascularization and microcirculatory improvement in musculoskeletal and soft tissue, which in turn promotes tissue regeneration. The unique shock waves used in PACE (Pulsed Acoustic Cellular Expression) technology are different from other familiar forms of acoustic energy, such as ultrasound. With PACE, the generated acoustic wave front represents a region of sudden and forceful change in stress, density, and temperature. It’s these shock waves that have been discovered to have a dramatic effect on living cells, and it’s this technology that SANUWAVE plans to ride into the future.

For additional information, visit the company’s website at www.SANUWAVE.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Monday, June 27, 2011

Hanmi Financial Corp. (HAFC) is “One to Watch”

Hanmi Financial Corporation, parent company of Hanmi Bank, a wholly-owned subsidiary, announced on June 20 that it has commenced a public offering of approximately $75 million in common stock. Hanmi Bank will use most of the proceeds from the offering to support future organic and acquisition driven growth.

Headquartered in Los Angeles, Hanmi Bank provides banking services to much of California, through 27 full-service offices, plus a loan office near Seattle, Washington. Hanmi Financial was established in 2000, but Hanmi Bank was founded in 1982. Originally aimed at the Korean-American Community, Hanmi Bank has grown to become the largest Korean-American Bank in the country, and has the fastest growing nationwide presence of any Korean-American bank. Today the bank is considered a leading community bank serving multi-ethnic customers in the Los Angeles, San Francisco, and San Diego areas. The bank specializes in commercial, SBA, trade finance, and consumer lending.

FBR Capital Markets & Co. will act as sole book-running manager for the public offering. Hanmi Financial expects to grant the underwriter a 30-day option to purchase up to $11.25 million of additional common stock for over-allotments, if any.

For additional information, visit the company’s website at www.Hanmi.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

GreenHouse Holdings, Inc. (GRHU) is “One to Watch”

In much the same way that companies specializing in information technology can help design, integrate, implement, and maintain IT systems for client businesses, there is a growing industry focused on helping businesses go green. The advantage, of course, is far more than a sense of sustaining the environment for future generations. Going green can have a significant positive impact on energy costs, as well as ensuring that government requirements and guidelines are being met.

A prime example of an expanding environmental technology support company is GreenHouse Holdings, Inc., based in San Diego. GreenHouse designs, engineers, and installs products and technologies that reduce energy costs and carbon footprint for the residential, commercial, industrial, government, and military markets. The goal is always to enable clients to monitor and control their energy costs, producing persistent technical and financial results, a foundational benefit that continues to give. With their knowledge of efficient building technologies, the company is also able to provide rapidly deployable facilities for use in disaster relief and security in austere environments, and their products represent a mix of capabilities for both permanent and temporary facilities and situations.

GreenHouse’s portfolio includes a variety of energy efficient products, energy management systems, eco-friendly infrastructure, scalable bio-fuel, and proprietary technologies. Flagship products include waste-to-fuel ethanol systems, a ready-to-deploy infrastructure of eco-friendly buildings and systems called the Green Village, RDU (Rapidly Deployable Unit) buildings that can be set up or taken down in less than an hour, and the 1-Link system for quickly integrating communications between diverse emergency providers. Regardless of the application, GreenHouse is now considered a leader in global sustainability systems integration.

In May, GreenHouse was awarded a $151 million contract to build a national security training center, the biggest contract in the company’s history. The Carlstrom National Security Training Center will be built in Central Florida, and was awarded to GreenHouse’s subsidiary, Life Protection, Inc., by the Pinnacle Performance Group. The center will be used by various military and government emergency response organizations, and will provide simulated training scenarios and classroom-based learning. It will take three years to complete.

For more information, visit the company’s website at www.GreenHouseIntl.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

China Sunergy Co. Ltd. (CSUN) Subsidiaries Ink Deal to Ramp Annual Silicon Cell Production

China Sunergy Co. Ltd., a China-based specialized solar cell and module manufacturer, today announced that its fully owned subsidiaries China Sunergy (HK) Co. Ltd. and China Sunergy (Nanjing) Co. Ltd. are co-investing in a 1GW solar cells expansion project in Yangzhou City, with the first batch of 500MW solar cells production line is expected to be commercialized in the first half of 2012.

The project will focus on the production of the newly developed Quasar cells, developed by China Sunergy, which have demonstrated the highest cell efficiency of 18.85 percent and an average efficiency of 18.55 percent from the best batch.

Today’s announced deal is expected to increase China Sunergy’s annual silicon cell production capacity to reach large-scale Quasar cell production efficiency of more than 19 percent in the first batch and 20 percent within two years.

Dr. Jianhua ZHAO, chief technology officer, said the company’s expectations are based on the company’s current equipment and R&D capability, and that the enhanced efficiency levels will result in significant cost-cuts for its customers.

“We believe solar industry has a very promising future. We take this golden opportunity to expand our production capacity and commercialize on our leading R&D technologies with the strong support of the Yi Zheng Development Zone,” Stephen Cai, CEO of China Sunergy stated in the press release. “We are confident that this 1GW production capabilities and highly efficient Quasar cells will provide us the scale and technological edge to be better positioned for industry growth and to become an industry leading player.”

China Sunergy noted that Yi Zheng Economic Development Zone has provided the company with 500 Mu (1 Mu=667 square meters) of land for industrial use, which includes comprehensive accessibility to local drainage, water, electricity, heating, gas supply, telecommunication and traffic. It has also provided a power station of 110KV prior to the construction of the facility.

For more information visit www.chinasunergy.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Passive Hypodermic Safety Syringe Introduced by MedPro Safety Products Inc. (MPSP)

MedPro Safety Products Inc. is a leading developer of safer medication delivery and blood collection systems. The company’s injection and infusion products incorporate needlestick prevention features considered to be the most passive now available on the market as they require little or no clinical training as compared to competitive products.

The company today announced the introduction of its hypodermic safety syringe. The device incorporates a proprietary safety shield that is automatically released during the administration of medicine, covering the needle as it is removed, and thereby enhancing the safety of both the patient and the health practitioner.

MedPro’s passive (automatic) hypodermic safety syringe provides unique features and benefits. The safety mechanism is integrated into the syringe and is activated through the normal process of medication delivery. The shield is automatically deployed over the contaminated needle, reducing the chances of a needlestick injury. It also prevents recapping, removal and reuse of the syringe with the engagement of its auto-diable feature and reduces the chance of blood or drug splatter.

The automatic hypodermic safety syringe is the latest product in the company’s efforts to expand its patented safety technology across a broad range of sectors. MedPro is currently in discussions with several potential partners to explore the commercialization of the hypodermic safety syringe. For more information on MedPro Safety Products, please visit its website at www.medprosafety.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

STAAR Surgical Co. (STAA) Completes First of Several Optical Procedures to Prepare for Full-Market Product Launch

STAAR Surgical Company, a developer, manufacturer and marketer of minimally invasive refractive lenses that go inside the eye, today announced it has completed the first of several procedures to implant Visian® Implantable Collamer® Lens (ICL™) V4c design.

The Visian V4c, which received European CE Mark approval in April, was designed to optimize the flow of fluid within the eye. The CentraFLOW™ proprietary technology eliminates the need for a surgical YAG peripheral iridotomy procedure days before the ICL implant, which the company said provides a more comfortable, convenient ICL procedure overall.

Dr. Erik Mertens, medical director and founder of the Medipolis Eye Centre in Antwerp, Belgium, implanted the Visian ICL V4c model in five eyes last Friday. These are the first procedures in a broader plan for eight sites and 100 eyes before the company conducts a full market launch in countries that accept CE Mark approvals.

“The V4c design offers significant benefits,” Dr. Mertens stated in the press release. “Since the approval late last year of the expanded range ICL, I have implanted the ICL in patients with as low as -1.5 diopters of myopia. Based on this initial experience, the new V4c design has proven to be more comfortable and convenient for the patient, as well as for me and my staff. Eliminating the iridotomy step puts the ICL procedure on the same level of efficiency as LASIK and it provides as good, if not better, visual results for the patient. … This latest ICL development eliminates a step in the procedure, and I believe this revolutionary CentraFLOW™ technology will be a game changer for implant-based refractive surgery.”

The company said the purpose of the pre-marketing procedures is to establish a strong marketing platform for the full launch, which the company said showcased at the upcoming ESCRS meeting in Vienna during September.

For more information visit www.staar.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Metropolitan Health (MDF) to Acquire ContinuCare (CNU), Maximize Expansion Potential

Metropolitan Health Networks Inc. today announced it will Continucare Corp. in a cash and stock transaction valued at approximately $416 million, creating a healthcare service provider to more than 68,000 Medicare Advantage and Medicaid customers.

The combined company will own 31 primary care medical practices in 18 Florida counties, utilizing a network of more than 250 contracted, independent, primary care practices.

Combined, the companies said they estimate approximately $660 million in annual revenue, based upon their respective results for the 12 months ended March 31, 2011, and more than $90 million in earnings before interest, taxes, depreciation and amortization (EBITDA) for the same period.

“In keeping with our mandate to achieve both organic and acquired growth, it gives us great pleasure to make today’s announcement,” Michael Earley, chairman and CEO of Metropolitan stated in the press release. “ … Each of our organizations have independently cultivated businesses that have little overlap and provide exemplary primary care to seniors and others in one of Florida’s fastest growing industries. Continucare is viewed as an accretive and a highly complementary acquisition for Metropolitan, one that we would be proud to culminate.”

Earley also noted that the companies expect the Medicare and Medicaid markets to grow significantly, and that the acquisition increases the companies’ potential for out of state expansion.

“… As our industry has evolved, we have sharpened our focus on providing the best possible care to our patients while continuing to create value to our shareholders,” commented Richard Pfenniger, chairman, CEO, and president of Continucare stated. “We expect that this transaction will bring resources to our customers and value to our shareholders, while providing stability to the employees of both of our companies, as they continue on a combined growth plan.”

Continucare common stock shareholders will receive $6.25 per share in cash, and 0.0414 of a share of Metropolitan common stock, equaling approximately $0.20 at the time of the announcement. The exact value of the will depend on Metropolitan’s share price at closing. Metropolitan expects to issue approximately 2.7 million shares in connection with the pending transaction.

For more information visit www.metcare.com or www.continucare.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Saturday, June 25, 2011

Uranium Energy Corp. (UEC) Mid-Year Report Bolster’s Confidence

The mid-year shareholder report recently issued by the CEO of Uranium Energy Corp., Amir Adnani, focused largely on the company’s updated uranium production numbers and its continued strong financial position, though perhaps the biggest news was UEC’s first multi-year uranium sales contract.

The recently announced sales contract calls for the delivery of 300,000 pounds of U308 over a period of three years, beginning in August of 2011. The U308 will come from UEC’s fully operational Hobson processing facility, between Corpus Christi and San Antonio in southeast Texas, one of the few fully licensed and permitted processing plants in the U.S. The delivered price for the uranium will be based on the published market price indicators at the time of delivery.

Uranium production at UEC’s Palangana Project in south Texas, approximately 100 miles south of the Hobson production facility, has more than doubled quarter over quarter, while production costs have declined. The site has already produced roughly 100,000 pounds of U308, and production ramp-up will continue as additional Palangana areas come on line.

In the meantime, development work continues to move forward on schedule at the company’s other sites. UEC expects their Goliad ISR (In-Situ Recovery) Project to become its second uranium producing asset in south Texas, with construction commencing as soon as they get final approval of the site’s RMS (Radioactive Materials License). The company’s Salvo Project, also in south Texas, is now undergoing Phase II drilling to confirm the current Inferred Resource Estimate, with drilling to continue throughout the summer. And finally, exploration is expected to begin within 90 days at UEC’s Coronel Oviedo site in Paraguay, South America.

Given that UEC now has close to 100,000 pounds of U3O8 in inventory, at a low cash operating expense, they are well positioned to generate cash flow from operations in 2011, and anticipate that any production will be sold through a combination of spot market sales and long-term contracts to help stabilize sales points and pricing.

The report’s conclusion that UEC is ideally positioned to participate in the recovery of the uranium sector is easy to support, given the company’s lack of debt, its proven ability to identify and develop some of the best uranium properties in the continental U.S., its verified capacity to cost effectively mine and process its own uranium, and now the company’s first major sale.

For more information on UEC, visit www.UraniumEnergy.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Friday, June 24, 2011

Uranium Energy Corp. (UEC) Completes Acquisition in Paraguay

U.S.-based Uranium Energy Corp. is an emerging uranium exploration, development and production company. The company recently announced that it completed the acquisition of a Paraguayan company which holds a 100% legal and beneficial interest in two unencumbered prospecting permits covering in total 247,000 acres located in the area of Coronel Oviedo in central Paraguay.

In order to complete the purchase, Uranium Energy has issued 225,000 restricted common shares. Once uranium is produced from the Coronel Oviedo Project, it will in addition pay a small royalty to the prior owner.

More of the uranium occurrences found on the property are ‘roll-front’ type deposits. These are similar to those currently producing uranium by low cost in-situ recovery methods in the western United States, central Asia and Australia. Prior to acquisition, Uranium Energy did have a company conduct an aquifer test as to whether the aquifer could sustain in-situ uranium recovery methods.

At present, Uranium Energy is preparing a geological model based on historical data for the property. The historical data is based on extensive uranium exploration by Anschutz Corporation between 1976 and 1983, and by Crescent Resources between 2006 and 2008. A total of 31 drill holes, out of 52, drilled by both companies showed significant uranium values. The known uranium mineralization indicated by the previous drilling occurred at depths between 450 and 750 feet. It also identified open-ended, tabular-like mineralization similar to that found at the company’s Goliad Project in Texas.

The company plans to pace its exploration program at Coronel Oviedo to be able to initiate an approximate 10,000 meter drilling program which is to occur during the third quarter of 2011. In order to support these operations in Paraguay, Uranium Energy has appointed Dr. Bernie Schmeling and Carlos Figueredo to a special advisory board.

Dr. Schmeling is a professional geophysicist, has more than 35 years’ experience in exploration and mining, and is internationally recognized as an expert in uranium in-situ mining. Mr. Figueredo has 25 years of experience in oil and mineral exploration in Paraguay. He formerly worked for Anschutz Corporation during its initial exploration efforts in the country and played a pivotal role in the earlier development of the Coronel Oviedo Project.

For more information on Uranium Energy Corporation, please visit the company’s website at www.uraniumenergy.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

D. Medical Industries Ltd. (DMED) Moves to Obtain CE Mark Approval for its Revolutionary Spring Zone Insulin Pump

D. Medical Industries, via its subsidiaries, is a constant innovator in cutting-edge medical devices sector for the delivery of diabetes treatments and other drugs. Today the Company announced submission of an application for CE Mark approval through its wholly owned Spring Health Solution Ltd subsidiary for the Spring™ Zone Insulin Delivery System.

The Spring Zone is a full replacement for generation one of the Company’s Spring ADI insulin pump and incorporates the proprietary Intellispring™ technology, resulting in vastly superior performance advantages in blockage, detachment direction, continuous insulin delivery checking and pressure/temp-related environmental adaptability. Also utilized in the product is the Company’s Total Line Control™ safety check system, resulting in full failsafe operability and offering what is arguably the safest and easiest means for reliably dispensing continuous, controlled and easily monitored insulin delivery.

COO at DMED, Hezkiah Tsoory, commented on the move for CE mark approval, explaining that, in addition to the EU’s 27 member nations, receipt of the CE mark will pave the way for market registrations in other regulated countries. Tsoory noted that among such countries are the Company’s five initial target markets for its pump products, namely Mexico and the BRIC nations.

The Spring Zone is the smallest, most lightweight insulin pump on the market today and offers an exceptionally quiet operational functionality, making it clearly superior to existing competition.

CCO for DMED, Zoe Myers, called the Spring Zone a hallmark of a new generation of diabetes support devices and explained that the elimination of the traditional motor and gear train in such pumps makes the Spring Zone more robust overall, with durability far exceeding anything else on the market.

The Company is also hard at work developing a single system which incorporates a continuous glucose monitoring system and an insulin pump.

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Uranium Energy Corp (UEC) CEO Comments on Uranium Market

The long term fundamentals of the uranium market remains solid and robust despite the temporary dislocation in the market caused by the tragedy that occurred at the Fukushima nuclear plant in Japan.

These comments and other observations on the current state of the uranium market were released by Amir Adnani, the President and CEO of Uranium Energy Corp. (UEC), as part of the company’s midyear update.

Nuclear power generation is still the best solution to the energy needs of the world’s rapidly increasing population as the technology is low cost and does not generate harmful greenhouse gases. Although demand for uranium will be reduced due to the German plan to close its reactors by 2022, this capacity reduction will be offset by numerous expansion as many emerging economies see the value in nuclear generation.

China alone has 27 nuclear plants under construction and another 52 plants being planned. By 2020, China will have added five times the capacity that Germany is shutting down. More than 65 new nuclear plants are under construction and another 155 are in the planning stage worldwide.

This fundamental outlook on the uranium market by Uranium Energy Corp. is supported by current prices. The spot price of uranium is $54.50 per pound, still far above the $40 per pound at this time last year. The term price is $68 per pound, down only slightly from before the events at the Fukushima plant.

For more information on the company, go to www.uraniumenergy.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Pfizer (PFE), Pain Therapeutics (PTIE) Receive Complete Response Letter from FDA for Pain Relief Candidate

Pfizer Inc. and Pain Therapeutics Inc. today announced they received word from the U.S. Food and Drug Administration (FDA) regarding the resubmission of a new drug application (NDA) for REMOXY® (oxycodone) Extended-Release Capsules CII.

REMOXY is an investigational extended-release oral formulation of oxycodone for the relief of moderate to severe pain.

In 2005, Pain Therapeutics signed an agreement with King Pharmaceuticals Inc. to develop and commercialize REMOXY. In 2008, Pain Therapeutics filed the initial NDA for REMOXY. The following year, King Pharmaceuticals assumed full control of drug development and filed a resubmission to the initial NDA in 2010.

Earlier this year, Pfizer acquired King Pharmaceuticals, thereby obtaining rights to REMOXY. The company is now working to respond and coordinate additional talks with the FDA.

“Pfizer is working to understand and address the issues in the FDA Complete Response Letter,” Olivier Brandicourt, Pfizer president and general manager of Primary Care stated in the press release. “Pain is an important strategic disease area for Pfizer. We share the concern about misuse and abuse of opioid medicines and are committed to being part of the solution to address this important public health and safety issue.”

For more information visit www.pfizer.com or www.paintrials.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Uranium Energy Corp. (UEC) Announces Developments on Palangana Project

Based in the United States with operations underway throughout North America, Uranium Energy Corp. is dedicated to furthering the production, development and exploration of uranium ore. UEC is focused on developing uranium sites and currently has two projects located in South Texas. One of these projects is the Palangana Project, which is an in-situ recovery (ISR) project that is steadily increasing production.

The Palangana Project is located in the South Texas uranium belt, a prime location for uranium development. Positioned approximately 100 miles south of the Hobson facility, the Palanga Project consists of approximately 6,200-acres. In the past, Union Carbide Corporation (UCC), Chevron and Everest Exploration Inc. drilled over 4,000 exploration, development and production holes. In the late 1970s, UCC produced uranium at the project using ISR technology. Harry Anthony, UEC’s Chief Operating Officer, was a member of UCC’s ISR mining team and oversaw the development and production of this project.

The latest 43-101 for Palangana was filed on Feb 23rd 2010. The Technical Report provides a Measured and Indicated Resource Estimate for the project of 1,057,000 pounds at an average grade of 0.135% eU3O8. This resource is located in two zones referred to as Production Area #1 and Production Area #2. An additional 1,154,000 pounds of eU3O8 at an average grade of 0.176% is classified as an Inferred Resource Estimate, and is located in six new exploration zones.

These resource estimates were completed by SRK Consulting U.S. Inc., and were based on the results from 2,694 drill holes at the Palangana Project completed by previous operators. The Resource Estimates are mainly located east of the Palangana Dome.

Uranium Energy has completed Phase I of the wellfield at Production Area 1, with more than 45 injection wells and production wells drilled, cased and tested. The average depth of wells throughout the PAA-1 wellfield is 450 feet. Each well has yielded promising volumes of water during each testing phase. UEC is adding gaseous oxygen and carbon dioxide to the circulating ground water, which has activated the mining process of dissolving the uranium from surrounding sandstones.

Phases II and III of the PAA-1 wellfield will each contain 45 production and injection wells. To date, all Phase II wells have been completed, and are targeted to commence mining this year. UEC has begun installation of Phase III wells with three rigs actively casing and then completing each well.

Additionally, UEC’s permitting and development teams are working towards bringing Palangana’s Production Area 2 closer to production. UEC’s exploration group commenced a drilling program during the third quarter consisting of approximately 50 holes at the proposed Production Area 3 wellfield. Resource expansion efforts are continuing in other areas at Palangana.

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

China GengSheng Minerals, Inc. (CHGS) Signs Agreement with US Company to Market and Distribute Products in North America

China GengSheng Minerals, Inc. recently announced that it has signed a five-year strategic partnership agreement with a U.S.-based strategic advisory, marketing and technology company for the marketing and distribution of its fracture proppant products in the North American market. China GengShen is a leading high-tech industrial materials manufacturer that specializes in producing heat resistant, energy efficient materials for a variety of industrial applications.

According to the agreement, the parties will collaborate on the development of the fracture proppant market in North America through the establishment of a jointly-owned brand that will be marketed to North American oil & gas producers. GengSheng will ship 4,000 metric tons of proppant products per month, beginning in July 2011, with volume increasing on a bi-monthly basis. Volume shipments are expected to reach at least 8,000 metric tons per month by October 2011.

“From our initial discussions with the partner, we were impressed not only with their capabilities, but also their deep knowledge of and strong connections within the North American fracture proppant market and oil & gas markets, and we believe they will be an ideal partner as we work to expand our presence internationally,” said Mr. Shunqing Zhang, Chairman and CEO of China GengSheng Minerals. “In addition to the significant revenue potential this partnership presents, it will provide us with our own brand specific to the North American market. The establishment of this brand will allow us to build awareness of GengSheng among international oil & gas customers, rather than remaining behind the scenes, as we had under our previous OEM sales model.”

Mr. Zhang added, “In order to better address the sizeable international growth opportunities in the proppant market, we have expanded our annual manufacturing capacity to 90,000 metric tons, and have begun construction on our second production facility, which will provide another 60,000 metric tons of capacity per year, beginning in the third quarter. Given our advanced technology, increased capacity and diversified marketing channels, we are confident in our ability to quickly capture meaningful share in the overseas fracture proppants market as it continues to mature.”

Under the agreement, GengSheng’s partner has the option to purchase quantities in excess of those stipulated in the contract, based on available capacity.

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

CorMedix, Inc. (CRMD) Notes Latest FDA Correspondence regarding Neutrolin®

CorMedix, Inc., a pharmaceutical company focused on developing and commercializing therapeutic products to prevent and treat cardiorenal disease, yesterday detailed its latest correspondence from the U.S. Food and Drug Administration (FDA) regarding the company’s regulatory submission for Neutrolin®.

Neutrolin is the CorMedix’s candidate for the prevention of catheter-related bloodstream infections. The company recently filed a Request for Designation (RFD), which allows the FDA to determine the product type and assign the product to the appropriate lead center.

In its filing, CorMedix proposed for Neutrolin to be classified as a device and assigned to the Center For Devices and Radiological Health as lead reviewer. The company noted that the RFD filing is the company’s response to communication from the FDA following CorMedix’s Investigational Device Exemption (IDE) amendment submission.

If the FDA hasn’t responded with a designation letter within 60 calendar days of the filing of the RFD, CorMedix’s recommendation will stand as the designated classification and assignment.

CorMedix expects to launch its clinical study of Neutrolin in the second half of 2011, contingent on the pending device designation and IDE approval.

CorMedix also said it expects to complete the initial submission of the Neutrolin Design Dossier to the European notified body by the end of the second quarter 2011.

For more information visit www.cormedix.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Uranium Energy Corp. (UEC) Owes It All to Experience

In a relatively short time, Uranium Energy Corp. has managed to separate itself from virtually every other uranium exploration company in the country. While other emerging companies have struggled both financially and technologically to establish themselves in the industry, UEC has been able to successfully identify and mine the most promising sites in the U.S., acquire and bring online one of the county’s few fully licensed and permitted uranium processing plants, and even secure a multi-year uranium sales contract for 300,000 pounds of uranium.

The reason for the dramatic difference between UEC and everyone else is clearly the technical team behind the company. Together they represent a depth of uranium industry experience unmatched for a developing company.

• Harry Anthony (COO, Director) is internationally recognized for his knowledge of the uranium industry. A professional engineer for 36 years, Mr. Anthony has gained particular recognition for his pioneering work in the field of In Situ Recovery (ISR), a far more cost effective and environmentally sound method of uranium extraction now used around the world.

• Clyde Yancey (VP of Exploration) has been heavily involved with the uranium industry for 33 years, from his initial work with the Uranium and Thorium Resources Branch of the USGS, through his years of industrial work in exploration and ISR. Mr. Yancey brings a special expertise in the field of reclamation, and is a Registered Professional Geologist in Wyoming and Texas.

• Robert Underdown (VP of Production) has held a variety of senior operational positions at ISR uranium mines in Texas since 1978, with an extensive background in the design, management, and reclamation of ISR uranium mines. He has a thorough working knowledge of regulatory agencies, and has held responsibility for the management and safety of hundreds of mining personnel.

• Curtis Sealy (VP of Health, Safety, and the Environment) is a Registered Professional Engineer with 40 years of experience in mine construction and other large-scale engineering projects, and has industrial uranium mining experience with several companies. Most recently he served as VP of Environmental and Regulatory Affairs for Energy Metals Corp., acquired by Uranium One in 2007.

• Ed Brezinski (VP of Marketing & Sales) has over 25 years of experience with utility companies and uranium commodity brokers, with a focus on the marketing of uranium and related products. Prior to joining UEC, he served as Vice President of Nuclear Fuel Supply for NYSE-listed Energy Solutions Inc.

• Leonard Garcia (VP of Land) brings over 30 years of experience in mineral title research, lease negotiations, and acquisitions. He has worked with some of the biggest energy related companies in the country and is a Registered Professional Landman.

For information on the full UEC technical team, visit www.UraniumEnergy.com/about_us/technical_team

For other information on UEC, visit www.UraniumEnergy.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Uranium Energy Corp. (UEC) Technical Analysis for Friday, June 24, 2011

UEC is forming a higher low and appears to be mounting a climb off the bottom. The indicators have turned and are trending towards bullish positions which will have the eyes of technical traders as resistance at $3.25 is being broken down.

To view the video chart, visit the following link: http://www.missionir.com/videos.html

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Thursday, June 23, 2011

SEFE, Inc. (SEFE) Announces Addition of Harold Sciotto to Board of Directors

SEFE, Inc., developer of an innovative solution designed to capture energy from our atmosphere, this morning announced the appointment of Harold Sciotto to its Board of Directors.

SEFE’s mission is to generate energy by harnessing static electricity in the atmosphere and converting it into an endless power supply. The company noted Mr. Sciotto’s experience in the alternative energy industry as complementary to development initiatives and the implementation of its business strategy.

Mr. Sciotto served as Corporate Secretary and Treasurer of ECOtality, Inc. (ECTY) from December of 2004 until November of 2010, and as a Director of the company from December of 2004 until October of 2009. While serving ECOtality, Electric Transportation Engineering Corporation (eTec), a subsidiary, announced it has officially signed a contract with the U.S. Department of Energy for a grant of $99.8 million to commence the largest deployment of electric vehicles (EVs) and charging infrastructure in U.S. history.

From June 1964 until his retirement in May 1993, Mr. Sciotto served Sears Roebuck & Company in various sales and management positions. These positions encompassed store sales and department management positions, store merchandise manager, district business manager, and store manager. He was also a managing partner of Smart Safe Homes, LLC, and has served as an independent business consultant to various business ventures.

“SEFE is completely unique in its pursuit of generating clean, carbon-free energy,” commented Mr. Sciotto. “I am very excited to be a part of this revolutionary initiative and believe the experience I’ve accumulated over the course of my career will help accelerate the company’s momentum.”

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Uranium Energy Corp. (UEC) Strong Track Record a Clear Indicator of Future Success

For investors interested in UEC, with 2011 only half way through, it’s useful to look back on some of the hard-won accomplishments of the previous year, gaining some perspective on what the company can do and which way it’s headed. Those accomplishments were summarized in the annual year-end letter to shareholders presented in December of 2010 by UEC’s President and CEO, Amir Adnani.

The major achievements of 2010 for UEC were in the areas of initial production, exploration, and financing.

• Initial Production – In November of 2010, UEC initiated uranium ISR (in-situ recovery) at their Palangana Project in south Texas, with the first uranium loaded resins being delivered to the company’s Hobson processing plant in Texas. The Hobson plant represents one of the few fully licensed and permitted uranium processing plants in the country, and soon began turning out the final product, marketable U308.

• Exploration and Development – By the end of the year, UEC was actively drilling at both the Palangana and the Salvo projects in south Texas, and had technical reports estimating resources in all categories at Palangana of 2.2 million pounds, and at Salvo of 1.5 million pounds. In addition, exploration and development work was continuing at other sites, including Goliad in Texas, where the company received its Mine Permit and Production Area Authorization and had technical reports estimating resources of 6.9 million pounds.

• Financing – In 2010, UEC received nearly $40 million, through $27.5 million in equity financing and the sale of a non-core asset for $11 million, giving the company an unusually strong financial position to continue investments in production and exploration.

2010 also saw increased analyst and media coverage for UEC, with analysts raising their price targets as goals were met. Forbes magazine published a feature article on the company in April of 2010 and CEO Adnani was interviewed by CNBC, The Wall Street Journal, Bloomberg, and Reuters. UEC was also added to the S&P/TSX Global Mining Index, an index of the world’s leading mining companies and, on November 19, 2010, the company had the honor of ringing the NYSE Closing Bell, marking the UEC’s transition from explorer to producer.

By the end of 2010, UEC was debt free, with $35 million in cash, one of the country’s strongest technical teams, and various uranium mining and processing operations in Texas under development or production, with a number of other promising sites around the country under consideration. Most importantly, the company had established itself as North America’s newest uranium producer.

The goal for 2011: Expanding production and generating cash flow.

For more information on UEC, visit www.UraniumEnergy.com

About MissionIR:

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html